Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International's Zyn ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United ...
The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
The FDA gave marketing authorization to 20 different Zyn products, the most popular nicotine pouch product in the U.S.
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.